glucagon has been researched along with guanabenz in 1 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (guanabenz) | Trials (guanabenz) | Recent Studies (post-2010) (guanabenz) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 446 | 42 | 96 |
| Protein | Taxonomy | glucagon (IC50) | guanabenz (IC50) |
|---|---|---|---|
| trace amine-associated receptor 1 | Homo sapiens (human) | 1.173 | |
| Solute carrier family 22 member 1 | Homo sapiens (human) | 4.85 | |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.204 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.041 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.149 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 1.106 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 2.068 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 1.787 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.472 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.392 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.204 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 2.068 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.097 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buckalew, VM; Eldridge, JC; Strandhoy, J | 1 |
1 trial(s) available for glucagon and guanabenz
| Article | Year |
|---|---|
Endocrinologic effects of antihypertensive therapy with guanabenz or hydrochlorothiazide.
Topics: Adult; Aged; Antihypertensive Agents; Double-Blind Method; Endocrine System Diseases; Female; Glucagon; Growth Hormone; Guanabenz; Guanidines; Humans; Hydrochlorothiazide; Hypertension; Insulin; Male; Middle Aged; Prolactin; Radioimmunoassay | 1984 |